Mizuho Starts Castle Biosciences (CSTL) at Outperform
Tweet Send to a Friend
Mizuho analyst Bradley Bowers initiates coverage on Castle Biosciences (NASDAQ: CSTL) with a Outperform rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




